Ana Carolina Caballero Gonzalez

10PUBLICATIONS
42CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsAutomotive safety engineeringAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jan 22, 2025
HSP-CAR30 with a high proportion of less-differentiated T cells promotes durable responses in refractory CD30+ lymphoma.

Ana Carolina Caballero, Cristina Ujaldón-Miró, Paula Pujol-Fernández

|Mar 15, 2023
Role of allogeneic hematopoietic cell transplant for relapsed/refractory aggressive B-cell lymphomas in the CART era.

Alberto Mussetti, Leyre Bento, Mariana Bastos-Oreiro

|Aug 28, 2022
High CAR intensity of expression confers enhanced antitumor effect against lymphoma without functional exhaustion.

Ana Carolina Caballero, Laura Escribà-Garcia, Paula Pujol-Fernández

|Feb 05, 2019
The novel agonistic iNKT-cell antibody NKT14m induces a therapeutic antitumor response against B-cell lymphoma.

Laura Escribà-Garcia, Carmen Alvarez-Fernández, Ana Carolina Caballero

Pageof 2